Amphia Hospital Breda, the Netherlands   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Breda Netherlands (2011)

Organization Overview

First Clinical Trial
2011
NCT00835471
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Amphia Hospital | Amphia Ziekenhuis, Breda, The Netherlands | R.S. Djamin

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Carcinoma, Non-Small-Cell Lung (Phase 2)

Cardiomyopathies (Phase 2)

Heart Arrest (Phase 2)

Hemorrhage (Phase 4)

Multiple Sclerosis (Phase 4)

Multiple Sclerosis, Relapsing-Remitting (Phase 4)

Pathologic Processes (Phase 2)

Sclerosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 15